1 (Image 1)
Bexarotene Capsule, Liquid Filled
Product Images NDC 0591-2832
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bexarotene (NDC 0591-2832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
This is a description of Bexarotene capsules, with a dosage of 75mg per capsule. Patients are instructed to read accompanying information carefully. The package insert contains complete preparing information, and the medication should be stored at a temperature between 20-25°C to protect it from light and high temperatures and humidity. The medication is manufactured by Teva Pharmaceuticals USA, Inc. and this is the NDC number 0591-2832-01.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
